CardioKinetix Initiates European Post-Market Trial of First-of-Its-Kind ... MarketWatch (press release) MENLO PARK, Calif., Jun 07, 2012 (BUSINESS WIRE) -- CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, announced today that it has begun enrollment in PARACHUTE III, a post-market safety surveillance ... CardioKinetix commences Parachute Ventricular Partitioning Device clinical ... |
